Amundi’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-52,117
Closed -$3.32M 1857
2025
Q3
$3.32M Buy
52,117
+26,582
+104% +$1.86M ﹤0.01% 1000
2025
Q2
$2.04M Sell
25,535
-106,952
-81% -$8.4M ﹤0.01% 1082
2025
Q1
$10.6M Buy
132,487
+37,326
+39% +$3.52M ﹤0.01% 819
2024
Q4
$8.39M Sell
95,161
-1,812
-2% -$186K ﹤0.01% 890
2024
Q3
$10.5M Sell
96,973
-84,388
-47% -$8.44M ﹤0.01% 839
2024
Q2
$17.4M Buy
181,361
+11,954
+7% +$1.19M 0.01% 729
2024
Q1
$16.3M Buy
169,407
+31,454
+23% +$2.77M 0.01% 741
2023
Q4
$12.1M Sell
137,953
-218,525
-61% -$17.4M 0.01% 805
2023
Q3
$25.9M Buy
356,478
+271,718
+321% +$22.5M 0.01% 652
2023
Q2
$7.27M Sell
84,760
-129,306
-60% -$10.5M ﹤0.01% 916
2023
Q1
$17.5M Buy
214,066
+129,698
+154% +$11.1M 0.01% 731
2022
Q4
$7.72M Sell
84,368
-265,633
-76% -$21.4M ﹤0.01% 907
2022
Q3
$26.8M Buy
350,001
+192,562
+122% +$17.3M 0.02% 632
2022
Q2
$13.6M Sell
157,439
-28,917
-16% -$2.99M 0.01% 704
2022
Q1
$19.9M Buy
186,356
+23,049
+14% +$2.7M 0.01% 665
2021
Q4
$20.7M Buy
163,307
+27,458
+20% +$3.05M 0.01% 670
2021
Q3
$13.7M Buy
135,849
+2,909
+2% +$321K 0.01% 768
2021
Q2
$15.5M Buy
+132,940
New +$16M 0.01% 738

Other funds holding EMN

Amundi's EMN Position: Q4 2025 in Review

Amundi sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 52,117 shares — an estimated $3.32M sold.

Amundi first reported a position in EMN in Q2 2021 and held it in 18 quarters. The position peaked at $26.8M in Q3 2022. 630 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Amundi reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • Amundi sold 52,117 Eastman Chemical shares in Q4 2025, an estimated $3.32M.
  • Amundi first reported a position in Eastman Chemical in Q2 2021 and held it in 18 quarters.
  • Amundi's Eastman Chemical position peaked at $26.8M in Q3 2022.
  • 630 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Amundi's 13F filing for Q4 2025, filed 17 Feb 2026.